Bowlus CL, Lim JK, Lindor KD. AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis: expert review. Clin Gastroenterol Hepatol 2019;17(12):2416–22. https://www.ncbi.nlm.nih.gov/pubmed/31306801
Boyer TD, Haskal ZJ, American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010;51(1):306. https://www.ncbi.nlm.nih.gov/pubmed/19902484
Chapman MH, Thorburn D, Hirschfield GM, Webster GGJ, Rushbrook SM, Alexander G, et al. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut 2019;68(8):1356–78. https://www.ncbi.nlm.nih.gov/pubmed/31154395
Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51(2):660–78. https://www.ncbi.nlm.nih.gov/pubmed/20101749
European Association for the Study of the Liver. Electronic address jee, European Association for the Study of the L. EASL Clinical Practice Guidelines on Sclerosing Cholangitis. J Hepatol 2022. https://www.ncbi.nlm.nih.gov/pubmed/35738507
European Society of Gastrointestinal Endoscopy, European Association for the Study of the Liver. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) clinical guidance. J Hepatol 2017;66(6):1265–81. https://www.ncbi.nlm.nih.gov/pubmed/28427764
Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009;50(3):808–14. https://www.ncbi.nlm.nih.gov/pubmed/19585548
Peng X, Luo X, Hou JY, Wu SY, Li LZ, Zheng MH, et al. Immunosuppressive agents for the treatment of primary sclerosing cholangitis: A systematic review and meta-analysis. Dig Dis 2017;35(5):478–85. https://www.ncbi.nlm.nih.gov/pubmed/28478443
Poropat G, Giljaca V, Stimac D, Gluud C. Bile acids for primary sclerosing cholangitis. Cochrane Database Syst Rev 2011;(1):CD003626. https://www.ncbi.nlm.nih.gov/pubmed/21249655
